3,4-MD-PCP

NMDA receptor affinity approximately 62 nM, placing potency between 3-MeO-PCP and ketamine. Users describe warm, chameleonic dissociation that varies dramatically with dose and setting, ranging from lucid sociability at low doses to overwhelming mania at high doses. The dose-response curve is steep above 40 mg. Batch purity varies; reagent testing strongly recommended. Start with minimal doses and titrate carefully.

Also known as: Mdpcp

Classification

Chemical: Arylcyclohexylamine
Psychoactive: Dissociative
Tag: Hallucinogen
Tag: Research-Chemical

Effects

Physical Disconnection
Physical Euphoria
Stimulation
Nystagmus
Incoordination
Insomnia
Cognitive Disconnection
Motor Control Loss
Depersonalization
Time Distortion
Analysis Enhancement
Dissociation
Tactile Enhancement
Tactile Suppression
Visual Drifting
Color Enhancement
Increased Music Appreciation
Open Eye Visuals

Routes of Administration

Oral

Dosage

Threshold: 3-5 mg
Light: 5-8 mg
Common: 8-20 mg
Strong: 20-40 mg
Heavy: 40 mg+

Duration

Onset: 0.25-0.75 h
Comeup: 0.5-1 h
Peak: 2-4 h
Offset: 3-5 h
After Effects: 4-48 h
Total Duration: 3-6 h

Insufflated

Dosage

Threshold: 2-3 mg
Light: 3-5 mg
Common: 5-15 mg
Strong: 15-30 mg
Heavy: 30 mg+

Duration

Onset: 0.08-0.25 h
Comeup: 0.25-0.5 h
Peak: 0.75-1.5 h
Offset: 3-5 h
After Effects: 3-48 h
Total Duration: 3-6 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

dose.wiki

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu